Protagonist Therapeutics Inc. (PTGX) Climbed 13.47% or 1.21 To Price $10.19 On Wednesday


Protagonist Therapeutics Inc. (PTGX) climbed 13.47% or 1.21 to $10.19. It is nearly 120018 shares traded, which is 75.46% compare to the average total volume 159043. The market cap of PTGX is $238.40 million. The year to date change is 43.81%. The 52 week price range is from $5.49 to $14.36. Price of PTGX have changed -10.91% during last week. It have changed -27.05% over last month, 27.38% over last 3 months, -0.77% over last 6 months and 6.65% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PTGX is 10.86. It is 6.58% above current price. The 200-day Moving Averages for PTGX is 8.85. It is -13.15% below current price. The 52-week High is 14.36. It is 40.92% from the current price. The 52-week Low is 5.49. It is -46.12% from current price.

There are some statistics of PTGX. It is has market cap $238.40 million. The share outstanding is 23.40 million. The average volume is 159043. The percent of top 15 Institution holding is 81.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PTGX is -34.15%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PTGX is -26.28%.


Tags:

Share this post